IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
IPSEN

BRIEF

published on 08/21/2026 at 07:05, 22 days 6 hours ago

Ipsen Acquires Kartos Therapeutics, Bolsters Oncology Pipeline

Oncology Pipeline Ipsen Myelofibrosis Navtemadlin Kartos Therapeutics
BRIEF

published on 08/21/2026 at 07:05, 22 days 6 hours ago

Ipsen strengthens its oncology offering with the acquisition of Kartos Therapeutics

Oncology Ipsen Myelofibrosis Navtemadlin Kartos Therapeutics
BRIEF

published on 08/21/2026 at 07:05, 22 days 6 hours ago

Ipsen acquiert Kartos Therapeutics et renforce son portefeuille de produits en oncologie

Ipsen Pipeline En Oncologie Myélofibrose Navtemadlin Kartos Thérapeutique
BRIEF

published on 08/21/2026 at 07:05, 22 days 6 hours ago

Ipsen consolide son offre en oncologie avec l'acquisition de Kartos Therapeutics

Oncologie Ipsen Myélofibrose Navtemadlin Kartos Therapeutics
PRESS RELEASE

published on 08/21/2026 at 07:00, 22 days 6 hours ago

Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée
Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée. Navtemadlin, inhibiteur de MDM2 en phase III dans la myélofibrose

Acquisition Portefeuille Oncologie Ipsen Navtemadlin
PRESS RELEASE

published on 08/21/2026 at 07:00, 22 days 6 hours ago

Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline. Acquisition includes Phase III clinical development of MDM2 inhibitor navtemadlin for myelofibrosis patients

Acquisition Oncology Pipeline Ipsen Navtemadlin Kartos Therapeutics
BRIEF

published on 08/20/2026 at 18:05, 22 days 19 hours ago

Évolution du Capital Social d'Ipsen en Juillet 2026

Euronext Paris Droits De Vote Capital Social Actions Ipsen
BRIEF

published on 08/20/2026 at 18:05, 22 days 19 hours ago

IPSEN fournit une mise à jour sur les droits de vote et le capital social pour juillet 2026

Euronext Paris Capital Social Droit De Vote Ipsen Juillet 2026
BRIEF

published on 08/20/2026 at 18:05, 22 days 19 hours ago

Evolution of Ipsen's Share Capital in July 2026

Euronext Paris Share Capital Voting Rights Actions Ipsen
BRIEF

published on 08/20/2026 at 18:05, 22 days 19 hours ago

IPSEN Provides Update on Voting Rights and Share Capital for July 2026

Euronext Paris Share Capital Voting Rights Ipsen July 2026

Accesswire

Published on 09/12/2026 at 02:35, 10 hours 55 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 30 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 25 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 5 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 30 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 5 hours 59 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 15 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 19 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 45 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 14 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE